Studies by Analysis Group Health Care Researchers Recognized by the Journal of Managed Care & Specialty Pharmacy

February 13, 2023

The Journal of Managed Care & Specialty Pharmacy’s list of “most cited” and “most viewed” papers in 2022 includes several studies with Analysis Group coauthors. In publishing the list, the JMCP notes:

The most viewed and cited articles from 2022 are reflective of JMCP’s mission to advance science, expertise, and evidence-based decision making to improve patient health through access to high-quality, cost-effective medications and other therapies. The highlighted articles underscore the importance of real-world evidence in managed care pharmacy decision making, as well as the importance of optimizing value and access.

Analysis Group congratulates the following authors on their accomplishments:

Most cited (#10): Vice President Keziah Cook, Manager Lamiya Sheikh, Senior Advisor Anita Chawla, “Health care resource utilization and costs among adult patients with hemophilia A on factor VIII prophylaxis: an administrative claims analysis”

Most viewed (#1): Managing Principal Eric Q. Wu, Vice President Yan Song, “Cost-effectiveness analysis of semaglutide 2.4 mg for the treatment of adult patients with overweight and obesity in the United States”

Most viewed (#10): Managing Principal Noam Kirson, Vice President Elyse Swallow, Vice President Debbie Goldschmidt, “Direct health care costs associated with COVID-19 in the United States”

JMCP’s “most cited” list also includes papers coauthored by Analysis Group academic affiliate Louis Garrison (#3) and Associate Woojung Lee (#12, while at the University of Washington).

View the full JMCP list here